Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA — Stella

Home/Coronary Arterial Disease (CAD)/

View on ClinicalTrials.gov

Recruiting

Back to Coronary Arterial Disease (CAD) trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Belgium

OLV Cardiovascular Center Aalst, Aalst, Flanders

Key details

Phase

Post-approval study

Sponsor

VZW Cardiovascular Research Center Aalst

Enrollment target

~46 participants

Started

July 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.